erythromycin has been researched along with Carcinoma, Epidermoid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagalas, V; Balassoulis, G; Chloros, D; Kontakiotis, T; Manika, K; Patakas, D; Porpodis, K; Sichletidis, L; Spyratos, D; Zarogoulidis, K | 1 |
| Dall, L; Martin, ML | 1 |
| Kitada, H; Konishi, Y; Murakawa, K; Sakitani, H; Sasaki, Y; Shiraiwa, K; Takahama, M; Tsujiuchi, T; Tsutsumi, M; Yoshimoto, M | 1 |
| Cheng, D; Tang, X | 1 |
| Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E | 1 |
| Engelhard, K; Reichardt, U | 1 |
| Guskey, LE; Wolff, DA | 1 |
1 trial(s) available for erythromycin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Retrospective Studies | 2000 |
6 other study(ies) available for erythromycin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drainage; Erythromycin; Female; Humans; Kidney Neoplasms; Male; Pleural Effusion, Malignant; Pleurodesis; Recurrence; Safety; Sclerosing Solutions; Treatment Outcome | 2008 |
Emergence of multidrug-resistant Mycobacterium fortuitum during treatment.
Topics: Carcinoma, Squamous Cell; Cefoxitin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1984 |
Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.
Topics: Adenocarcinoma; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Carcinogens; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cocarcinogenesis; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drugs, Chinese Herbal; Erythromycin; Gene Expression Regulation; Inflammation; Lung Neoplasms; Macrophages; Male; Neutrophils; Nitrosamines; Penicillins; Piroxicam; Plant Extracts; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Specific Pathogen-Free Organisms | 2000 |
[The value of erythromycin pleurodesis in the treatment of malignant pleural effusions].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Erythromycin; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurodesis | 1997 |
[Pneumonia of unknown origin in immunosuppressed patients. Antibiotic therapy].
Topics: Anti-Bacterial Agents; Carcinoma, Squamous Cell; Erythromycin; Humans; Male; Middle Aged; Mouth Neoplasms; Opportunistic Infections; Pneumonia | 1987 |
Effects of actinomycin D on the cytopathology induced by poliovirus in HEp-2 cells.
Topics: Carcinoma, Squamous Cell; Cell Fractionation; Cell Line; Cytopathogenic Effect, Viral; Dactinomycin; Erythromycin; Galactosidases; Glucuronidase; Humans; Laryngeal Neoplasms; Lysosomes; Microscopy, Phase-Contrast; Poliovirus; RNA, Neoplasm; Tritium; Uridine; Virus Replication | 1974 |